Clinical Trial Update: Comprehensive HHT Outcomes Registry of the United States (CHORUS)

View source ↗

Summary

CHORUS is a comprehensive United States outcomes registry for hereditary hemorrhagic telangiectasia (HHT) and related vascular malformations, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Malformation
• Cerebral Arteriovenous Malformation
• Epistaxis
• Gastrointestinal Bleeding
• Hereditary Hemorrhagic Telangiectasia
• Telangiectasia
• Vascular Malformation

Snippet

Sponsor: Cure HHT | Conditions: Hereditary Hemorrhagic Telangiectasia, Arteriovenous Malformations | Status: RECRUITING